Amgen, a biotechnology pioneer, harnesses the power of cellular and molecular biology and medicinal chemistry to discover, develop and deliver innovative human therapeutics to dramatically improve people’s lives. Our vital medicines have helped more than eight million patients in their fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. Interdisciplinary research and development efforts and world-class manufacturing and commercialization capabilities have established Amgen as a leader in the biotechnology industry. With a broad and deep pipeline of potential therapeutic candidates, we continue to advance science to serve patients.
Fighting serious illness takes more than pioneering science and vital medicines, it also takes commitment and resources. AmgenMED partners with those dedicated to improving the quality of patients’ lives. Through AmgenMED, we make contributions available for educational, scientific and a variety of other charitable purposes to support the people and organizations that make it all possible.
